RaySearch Laboratories AB (FRA:27R) Cyclically Adjusted Book per Share: €2.02 (As of Mar. 2026)


FRA:27R RaySearch Laboratories AB FRA:27R
86 GF Score
Price €20.86
GF Value €16.85
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is RaySearch Laboratories AB Cyclically Adjusted Book per Share?

RaySearch Laboratories AB FRA:27R +2.36% 86 Cyclically Adjusted Book per Share is €2.02 as of Mar. 2026. GuruFocus rates FRA:27R with a GF Score™ of 86/100 and a GF Value™ of €16.85 (Modestly Overvalued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

RaySearch Laboratories AB's adjusted book value per share for the three months ended in Mar. 2026 was €2.824. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €2.02 for the trailing ten years ended in Mar. 2026.

During the past 12 months, RaySearch Laboratories AB's average Cyclically Adjusted Book Growth Rate was 8.00% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 9.50% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 13.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of RaySearch Laboratories AB was 16.90% per year. The lowest was 9.50% per year. And the median was 14.65% per year.

As of today (2026-07-13), RaySearch Laboratories AB's current stock price is €20.86. RaySearch Laboratories AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was €2.02. RaySearch Laboratories AB's Cyclically Adjusted PB Ratio of today is 10.33.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of RaySearch Laboratories AB was 32.53. The lowest was 2.88. And the median was 7.99.


RaySearch Laboratories AB  (FRA:27R) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

RaySearch Laboratories AB's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=20.86/2.02
=10.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of RaySearch Laboratories AB was 32.53. The lowest was 2.88. And the median was 7.99.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


RaySearch Laboratories AB Cyclically Adjusted Book per Share Related Terms


RaySearch Laboratories AB Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for RaySearch Laboratories AB's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RaySearch Laboratories AB Cyclically Adjusted Book per Share Chart

RaySearch Laboratories AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.32 1.47 1.68 1.77 2.05

RaySearch Laboratories AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.03 1.92 1.94 2.05 2.02

FRA:27R vs VEEV, BTSG, TEM: Cyclically Adjusted Book per Share Comparison

For the Health Information Services subindustry, RaySearch Laboratories AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


RaySearch Laboratories AB Cyclically Adjusted PB Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, RaySearch Laboratories AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where RaySearch Laboratories AB's Cyclically Adjusted PB Ratio falls into.


FRA:27R
86GF Score
RaySearch Laboratories AB FRA:27R
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

RaySearch Laboratories AB Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, RaySearch Laboratories AB's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=2.824/133.5600*133.5600
=2.824

Current CPI (Mar. 2026) = 133.5600.

RaySearch Laboratories AB Quarterly Data

Book Value per Share CPI Adj_Book
201606 1.115 101.019 1.474
201609 1.176 101.138 1.553
201612 1.382 102.022 1.809
201703 1.489 102.022 1.949
201706 1.520 102.752 1.976
201709 1.553 103.279 2.008
201712 1.705 103.793 2.194
201803 1.700 103.962 2.184
201806 1.735 104.875 2.210
201809 1.748 105.679 2.209
201812 1.867 105.912 2.354
201903 1.868 105.886 2.356
201906 1.905 106.742 2.384
201909 1.874 107.214 2.335
201912 1.963 107.766 2.433
202003 2.003 106.563 2.510
202006 2.049 107.498 2.546
202009 1.985 107.635 2.463
202012 1.991 108.296 2.455
202103 2.015 108.360 2.484
202106 1.977 108.928 2.424
202109 1.906 110.338 2.307
202112 1.784 112.486 2.118
202203 1.853 114.825 2.155
202206 1.737 118.384 1.960
202209 1.742 122.296 1.902
202212 1.744 126.365 1.843
202303 1.754 127.042 1.844
202306 1.720 129.407 1.775
202309 1.748 130.224 1.793
202312 1.917 131.912 1.941
202403 2.002 132.205 2.023
202406 1.985 132.716 1.998
202409 2.083 132.304 2.103
202412 2.223 132.987 2.233
202503 2.455 132.825 2.469
202506 2.248 133.699 2.246
202509 2.438 133.480 2.439
202512 2.641 133.390 2.644
202603 2.824 133.560 2.824

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €2.02 mean?
RaySearch Laboratories AB (FRA:27R) has a Cyclically Adjusted Book per Share of €2.02 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on RaySearch Laboratories AB and its competitors.
Is RaySearch Laboratories AB's Cyclically Adjusted Book per Share too high?
RaySearch Laboratories AB's current Cyclically Adjusted Book per Share is €2.02. Overall, RaySearch Laboratories AB has a GF Score™ of 86/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does RaySearch Laboratories AB's Cyclically Adjusted Book per Share compare to VEEV and BTSG?
RaySearch Laboratories AB's Cyclically Adjusted Book per Share of €2.02 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted Book per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on RaySearch Laboratories AB and its competitors. RaySearch Laboratories AB's current Cyclically Adjusted Book per Share is €2.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RaySearch Laboratories AB stock overvalued right now?
Based on GuruFocus' analysis, RaySearch Laboratories AB (FRA:27R) is currently considered Modestly Overvalued. The stock's GF Value™ is €16.85, compared to a current price of €20.86 — trading 23.8% above its estimated fair value. The current Cyclically Adjusted Book per Share is €2.02. RaySearch Laboratories AB's overall GF Score™ is 86/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For RaySearch Laboratories AB (FRA:27R), the current Cyclically Adjusted Book per Share is €2.02 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is RaySearch Laboratories AB (FRA:27R) Overvalued in 2026?

Based on GuruFocus' analysis, RaySearch Laboratories AB stock appears to be overvalued. The current stock price of €20.86 is trading 23.8% above its estimated GF Value™ of €16.85. GuruFocus considers RaySearch Laboratories AB to be Modestly Overvalued.

Key valuation signals for FRA:27R:

  • Cyclically Adjusted Book per Share: €2.02
  • GF Value™: €16.85 vs. price of €20.86 (23.8% above fair value)
  • GF Score™: 86/100 with 2 warning signs

No single metric tells the full story. See the FRA:27R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


RaySearch Laboratories AB Business Description

Address Eugeniavagen 18C, Stockholm, SWE, 113 68
RaySearch Laboratories AB is a Sweden-based medical technology company. The company develops software solutions for improved cancer treatment. The company develops and markets the RayStation treatment planning system and RayCare oncology information system to clinics all over the world and distributes products through licensing agreements with medical technology companies. Its geographic segments consist of the Americas, Asia-Pacific & Middle East, Europe, and the rest of world.
86GF Score

Get the complete analysis for FRA:27R

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€20.86
Price
€16.85
GF Value